Johnson & Johnson’s consumer-health spinoff Kenvue became the biggest U.S. IPO in over a year, with a 22% jump after its market debut on the New York Stock Exchange. The events of May 4, 2023, puts the company roughly at a value of $50 billion. Trading under the ticker KVUE, the company holds a range …
Continue reading “Kenvue Debuts Historically with a 22% Jump in the Public Market”